Search
Dexamethasone Treatment Options
A collection of 1455 research studies where Dexamethasone is the interventional treatment. These studies are located in the United States. Dexamethasone is used for conditions such as Multiple Myeloma, Lymphoma and Postoperative Pain.
565 - 576 of 1455
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Chronic Cough Research Study
Recruiting
Are you tired of living with chronic cough? Our research study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough.
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!
Conditions:
Chronic Cough
Refractory or Unexplained Chronic Cough
Cough
Asthma
Sinusitis
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
Active Not Recruiting
This phase I trial will assess primarily the safety and secondarily anti-inflammatory effect of Episcleral Dexamethasone in patients suffering from refractory diabetic macular edema.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/21/2023
Locations: Stanford Medicine Ophthalmology, Palo Alto, California
Conditions: Refractory Diabetic Macular Edema
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
Completed
To compare the signs and symptoms of dry eye after cataract surgery between subjects randomized to receive intraoperative dexamethasone in addition to the use of a standard topical post-op treatment regimen.
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
11/20/2023
Locations: Hauser Ross Surgical Center, Sycamore, Illinois
Conditions: Dry Eye Syndromes
Dexamethasone Versus Depo Medrol in Lumbar Epidurals
Terminated
Comparison of Dexamethasone versus Depo Medrol when used in lumbar epidural injections will be conducted on subjects that have not had previous injections or have not had an injection in the last 12 months. Subjects must be receiving one level injection and not had prior surgery at that level.
Gender:
ALL
Ages:
Between 21 years and 89 years
Trial Updated:
11/20/2023
Locations: Upstate Orthpedics, East Syracuse, New York
Conditions: Lumbar Spine Disc Herniation, Lumbar Radiculitis, Lumbar Back Pain
Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial
Recruiting
This phase I/II trial studies the safety of the combination of bortezomib, dexamethasone, and pembrolizumab with or without pelareorep in treating patients with multiple myeloma that has come back (relapsed) or does not response to treatment (refractory). Chemotherapy drugs, such as bortezomib and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/15/2023
Locations: Los Angeles County-USC Medical Center, Los Angeles, California +1 locations
Conditions: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
Completed
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 administered to patients with relapsed, refractory hematologic malignancies, including multiple myeloma, lymphoma, and others.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/13/2023
Locations: Rocky Mountain Cancer Centers, Denver, Colorado +7 locations
Conditions: Hematologic Malignancy
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
Recruiting
Stomach cancer is the fifth most common digestive cancer and third main cause of death from cancer in the world. Modern management of Gastric cancer involves a multi-disciplinary approach involving surgical oncologists, medical oncologists, gastroenterologists and oncological radiologists. The most common clinical approach to Gastric adenocarcinoma is to begin with staging, which usually involves CT scan/ MRI combined with endoscopic US for more accurate T, N staging. Once the patient is deemed... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/13/2023
Locations: Mount Sinai West, New York, New York +2 locations
Conditions: Gastric Cancer, Stomach Cancer
Low Dose Aprepitant for Patients Receiving Carboplatin
Terminated
This study evaluates a simple one day prophylaxis of nausea and vomiting for patients who are getting carboplatin based chemotherapy. In addition to standard oral Dexamethasone and oral Ondansetron, participants will be given a third neurokinin 1 (NK1) antagonist agent, either a single dose of oral Aprepitant or intravenous (IV) Fosaprepitant (they have been shown to be equally effective) to improve prevention of nausea and vomiting. No medications need to be taken beyond day 1.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/09/2023
Locations: Jacobi Medical Center, Bronx, New York +1 locations
Conditions: Chemotherapy-induced Nausea and Vomiting
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Active Not Recruiting
This randomized phase I/II trial studies the side effects and best dose of pomalidomide and ixazomib when given together with dexamethasone and to see how well pomalidomide and dexamethasone with or without ixazomib works in treating patients with multiple myeloma that has come back. Biological therapies, such as pomalidomide and dexamethasone, may stimulate the immune system in different ways and stop cancer cells from growing. Ixazomib may stop the growth of cancer cells by blocking some of th... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/09/2023
Locations: Anchorage Associates in Radiation Medicine, Anchorage, Alaska +335 locations
Conditions: Multiple Myeloma in Relapse
MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty
Completed
Compare the outcome following manipulation under anesthesia for stiffness in a randomized controlled fashion with one group receiving IV dexamethasone and oral celecoxib at the time of manipulation to a control group receiving manipulation alone.
Outcomes will include pain, range of motion, as well as subjective outcome scores.
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
11/02/2023
Locations: HipKnee Arkansas Foundation, Little Rock, Arkansas +15 locations
Conditions: Stiffness Following Total Knee Arthroplasty
Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
Active Not Recruiting
The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction and 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive function associated with sleep restriction, including food intake and food cravings.
Gender:
ALL
Ages:
Between 60 years and 80 years
Trial Updated:
11/02/2023
Locations: Los Angeles Biomedical Research Institute, Torrance, California
Conditions: Sleep Restriction
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Terminated
The purpose of this clinical research study is to evaluate the safety and effectiveness (good and bad effects) of pomalidomide given as part of a combination therapy that include more than just steroids to treat subjects with relapsed (subjects whose disease came back) or refractory (subjects whose disease did not respond to past treatment) multiple myeloma (MM).
Pomalidomide (alone or in combination with dexamethasone) has been approved by the United States Food and Drug Administration (FDA) f... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/01/2023
Locations: California Cancer Associates for Research & Excellence (cCARE), Encinitas, California +11 locations
Conditions: Multiple Myeloma
iPACK Block With Dexamethasone For Total Knee Replacement
Terminated
Comparing the pain control outcomes for patients undergoing total knee arthroplasty (TKA) with either: 1) adductor canal single shot injection plus placebo iPACK injection or 2) adductor canal single shot injection plus bupivacaine and dexamethasone iPACK injection.
There are two surgical approaches for TKA 1) open 2) ROSA robotic assisted. Both follow the same pain management pathway. We plan to enroll patient undergoing either surgical procedure.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/01/2023
Locations: University of California, San Diego, San Diego, California
Conditions: Knee Osteoarthritis, Acute Pain, Anesthesia, Local, Regional Anesthesia
565 - 576 of 1455